PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pediatrics and.\', \'Division of Hematology/Oncology/Blood and Marrow Transplant, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.\', \'Children\'s Research Institute, Children\'s Hospital of Wisconsin, Milwaukee, WI.\', \'Division of Quantitative Health Sciences, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI; and.\', \'Clinical and Translational Science Institute of Southeastern Wisconsin, Milwaukee, WI; and.\', \'Division of Critical Care, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1182/bloodadvances.2021004288
?:hasPublicationType
?:journal
  • Blood advances
is ?:pmid of
?:pmid
?:pmid
  • 34196678
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all